Green Plains Inc
NASDAQ:GPRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Green Plains Inc
NASDAQ:GPRE
|
US |
|
F
|
First Hydrogen Corp
F:FIT
|
CA |
|
Tele2 AB
F:NCYD
|
SE |
|
A
|
Archean Chemical Industries Ltd
NSE:ACI
|
IN |
|
Pierre et Vacances SA
PAR:VAC
|
FR |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
A
|
Alpha Services and Holdings SA
SWB:ACBB
|
GR |
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
KR |
Wall St Price Targets
GPRE Price Targets Summary
Green Plains Inc
According to Wall Street analysts, the average 1-year price target for
GPRE is 16.9 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GPRE's stock price target?
Price Target
16.9
USD
According to Wall Street analysts, the average 1-year price target for
GPRE is 16.9 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.
What is the Revenue forecast for Green Plains Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 5 years is 14%.
What is the Gross Profit forecast for Green Plains Inc?
Projected CAGR
54%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 54%.